Annual Accounts Receivable
N/A
December 1, 2024
Summary
- SNY annual accounts receivable is not available.
Performance
SNY Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
December 1, 2024
Summary
- SNY quarterly accounts receivable is not available.
Performance
SNY Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
SNY Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
SNY Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Sanofi Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $9.12 B(-2.1%) |
| Dec 2023 | $9.32 B(+3.2%) | $9.32 B(+3.5%) |
| Jun 2023 | - | $9.01 B(-0.3%) |
| Dec 2022 | $9.03 B(+5.4%) | $9.03 B(+9.9%) |
| Jun 2022 | - | $8.22 B(-4.1%) |
| Dec 2021 | $8.57 B(-7.9%) | $8.57 B(+5.9%) |
| Jun 2021 | - | $8.09 B(-0.1%) |
| Dec 2020 | $9.31 B(+4.7%) | - |
| Jun 2020 | - | $8.10 B(-8.9%) |
| Dec 2019 | $8.89 B(+7.1%) | $8.89 B(+8.2%) |
| Jun 2019 | - | $8.22 B(-1.0%) |
| Dec 2018 | $8.30 B(-4.1%) | $8.30 B(+8.8%) |
| Jun 2018 | - | $7.63 B(-11.8%) |
| Dec 2017 | $8.66 B(+12.0%) | $8.66 B(+12.0%) |
| Dec 2016 | $7.73 B(-4.3%) | $7.73 B(-4.3%) |
| Dec 2015 | $8.08 B(-7.1%) | $8.08 B(-7.3%) |
| Jun 2015 | - | $8.71 B(+0.2%) |
| Dec 2014 | $8.69 B(-7.8%) | $8.69 B(-10.7%) |
| Jun 2014 | - | $9.74 B(+3.2%) |
| Dec 2013 | $9.43 B(-5.0%) | $9.43 B(-4.9%) |
| Jun 2013 | - | $9.92 B(-0.0%) |
| Dec 2012 | $9.93 B(-4.7%) | $9.93 B(-2.6%) |
| Jun 2012 | - | $10.19 B(-2.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $10.42 B(+20.4%) | $10.42 B(-6.7%) |
| Jun 2011 | - | $11.16 B(+29.0%) |
| Dec 2010 | $8.65 B(+0.6%) | $8.65 B(+1.3%) |
| Jun 2010 | - | $8.54 B(-0.7%) |
| Dec 2009 | $8.60 B(+16.1%) | $8.60 B(+4.4%) |
| Jun 2009 | - | $8.24 B(+11.2%) |
| Dec 2008 | $7.41 B(+3.5%) | $7.41 B(-9.0%) |
| Jun 2008 | - | $8.15 B(+13.8%) |
| Dec 2007 | $7.16 B(+7.8%) | $7.16 B(+0.2%) |
| Jun 2007 | - | $7.14 B(+7.6%) |
| Dec 2006 | $6.64 B(+11.8%) | $6.64 B(-1.3%) |
| Jun 2006 | - | $6.73 B(+13.2%) |
| Dec 2005 | $5.94 B(-1.6%) | $5.94 B(+1.3%) |
| Jun 2005 | - | $5.86 B(-2.9%) |
| Dec 2004 | $6.04 B(+222.3%) | $6.04 B(+174.9%) |
| Jun 2004 | - | $2.20 B(+17.2%) |
| Dec 2003 | $1.87 B(+36.1%) | $1.87 B(+5.1%) |
| Jun 2003 | - | $1.78 B(+29.4%) |
| Dec 2002 | $1.38 B(-1.2%) | $1.38 B(-7.3%) |
| Jun 2002 | - | $1.49 B |
| Dec 2001 | $1.39 B(+20.2%) | - |
| Dec 2000 | $1.16 B(+4.9%) | - |
| Dec 1999 | $1.10 B | - |
FAQ
- What is the all time high annual accounts receivable for Sanofi?
- What is the all time high quarterly accounts receivable for Sanofi?
What is the all time high annual accounts receivable for Sanofi?
Sanofi all-time high annual accounts receivable is $10.42 B
What is the all time high quarterly accounts receivable for Sanofi?
Sanofi all-time high quarterly accounts receivable is $11.16 B